Omaxe Ltd
Omaxe ltd. is in the business of developing real estate properties for residential, commercial and retail purposes with a presence across 27 cities in 8 states of India. It has undertaken various projects in the areas of contractual construction, township development, building of commercial complexes, multi-storied apartments, etc.
[1] [2]
- Market Cap ₹ 1,463 Cr.
- Current Price ₹ 80.1
- High / Low ₹ 127 / 68.8
- Stock P/E
- Book Value ₹ 35.9
- Dividend Yield 0.00 %
- ROCE -8.81 %
- ROE -29.6 %
- Face Value ₹ 10.0
Pros
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -12.9% over past five years.
- Company has a low return on equity of -19.8% over last 3 years.
- Contingent liabilities of Rs.1,719 Cr.
- Company has high debtors of 192 days.
- Company's cost of borrowing seems high
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Consumer Discretionary Realty Realty Residential, Commercial Projects
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,175 | 931 | 961 | 1,037 | 1,268 | 768 | 780 | 252 | 412 | 459 | 705 | 390 | 429 | |
| 982 | 750 | 771 | 822 | 1,058 | 656 | 619 | 358 | 368 | 561 | 740 | 506 | 499 | |
| Operating Profit | 194 | 181 | 190 | 214 | 210 | 113 | 160 | -105 | 44 | -101 | -34 | -116 | -70 |
| OPM % | 16% | 19% | 20% | 21% | 17% | 15% | 21% | -42% | 11% | -22% | -5% | -30% | -16% |
| 36 | 39 | 56 | 42 | 46 | 160 | 137 | 31 | 11 | 12 | 11 | 60 | 29 | |
| Interest | 137 | 135 | 138 | 121 | 154 | 224 | 201 | 149 | 103 | 105 | 114 | 123 | 127 |
| Depreciation | 9 | 13 | 9 | 6 | 6 | 7 | 67 | 57 | 39 | 56 | 45 | 26 | 26 |
| Profit before tax | 84 | 72 | 98 | 129 | 96 | 42 | 29 | -280 | -88 | -250 | -183 | -205 | -193 |
| Tax % | 29% | 44% | 46% | 47% | 34% | 44% | 422% | -25% | -13% | -23% | -23% | 6% | |
| 60 | 40 | 53 | 68 | 64 | 23 | -94 | -210 | -76 | -193 | -140 | -217 | -189 | |
| EPS in Rs | 3.30 | 2.19 | 2.88 | 3.71 | 3.47 | 1.27 | -5.16 | -11.49 | -4.17 | -10.56 | -7.67 | -11.87 | -10.32 |
| Dividend Payout % | 15% | 23% | 24% | 19% | 20% | 55% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -8% |
| 5 Years: | -13% |
| 3 Years: | -2% |
| TTM: | -33% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | -48% |
| 3 Years: | % |
| TTM: | -7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | 4% |
| 3 Years: | -3% |
| 1 Year: | -34% |
| Return on Equity | |
|---|---|
| 10 Years: | -5% |
| 5 Years: | -16% |
| 3 Years: | -20% |
| Last Year: | -30% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 |
| Reserves | 1,450 | 1,479 | 1,632 | 1,685 | 1,742 | 1,407 | 1,308 | 1,099 | 1,025 | 832 | 691 | 475 |
| 1,304 | 1,303 | 1,010 | 933 | 1,054 | 874 | 975 | 811 | 606 | 396 | 270 | 279 | |
| 1,888 | 1,996 | 2,642 | 2,890 | 2,447 | 3,915 | 3,666 | 3,871 | 4,035 | 4,399 | 4,750 | 5,354 | |
| Total Liabilities | 4,826 | 4,960 | 5,467 | 5,690 | 5,426 | 6,379 | 6,133 | 5,963 | 5,848 | 5,809 | 5,893 | 6,290 |
| 39 | 29 | 505 | 501 | 504 | 504 | 653 | 591 | 545 | 508 | 493 | 484 | |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 384 | 271 | 301 | 330 | 331 | 290 | 294 | 294 | 295 | 336 | 384 | 394 |
| 4,404 | 4,660 | 4,660 | 4,859 | 4,591 | 5,584 | 5,186 | 5,078 | 5,008 | 4,964 | 5,017 | 5,413 | |
| Total Assets | 4,826 | 4,960 | 5,467 | 5,690 | 5,426 | 6,379 | 6,133 | 5,963 | 5,848 | 5,809 | 5,893 | 6,290 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56 | 113 | 222 | 318 | 29 | 271 | 293 | 55 | 144 | 30 | 411 | 585 | |
| 15 | 128 | 29 | -16 | 21 | 136 | 34 | 299 | 228 | 268 | -79 | -431 | |
| -77 | -277 | -273 | -295 | -44 | -426 | -348 | -334 | -353 | -312 | -323 | -177 | |
| Net Cash Flow | -6 | -36 | -22 | 6 | 6 | -18 | -21 | 19 | 19 | -14 | 9 | -22 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 235 | 215 | 186 | 267 | 176 | 109 | 103 | 355 | 218 | 199 | 124 | 192 |
| Inventory Days | 10,183 | 4,593 | 1,022 | 13,102 | 3,441 | 20,019 | 4,769 | |||||
| Days Payable | 2,084 | 1,182 | 336 | 2,231 | 614 | 3,579 | 918 | |||||
| Cash Conversion Cycle | 235 | 215 | 8,285 | 3,679 | 863 | 10,980 | 2,930 | 16,795 | 218 | 199 | 3,975 | 192 |
| Working Capital Days | 463 | 695 | 577 | 518 | 382 | 323 | 314 | 520 | 145 | -158 | -256 | -712 |
| ROCE % | 8% | 7% | 8% | 9% | 9% | 10% | 10% | -6% | 1% | -9% | -5% | -9% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Credit Rating
2d - CARE reaffirmed Omaxe ratings: CARE BB+; Stable and CARE A4+ on Oct 18, 2025; one rating withdrawn.,
-
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
14 Oct - Subsidiary Omaxe Garv receives RERA registration UPRERAPRJ845286/10/2025 for 'The Nest' in Lucknow; valid till 31-08-2027.
-
Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015
7 Oct - Gardenia Floors Phase 2 RERA registered (PBRERA-SAS80-PR1260); launch 08-10-2025; valid until 11-12-2029.
-
General Update Under Regulation 30 Of The SEBI (LODR) Regulations, 2015, As Amended ("SEBI LODR Regulations, 2015")
30 Sep - AGM Sep 29, 2025: shareholders approved two director reappointments and DMK as secretarial auditors FY2025-26–2029-30.
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 30 Sep
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from nse
Concalls
-
Jul 2020TranscriptNotesPPT
-
May 2018TranscriptNotesPPT
-
Feb 2018TranscriptNotesPPT
-
Nov 2017TranscriptNotesPPT
-
Aug 2017TranscriptNotesPPT
-
Jun 2017TranscriptNotesPPT
-
Feb 2017TranscriptNotesPPT
-
Dec 2016TranscriptNotesPPT
-
May 2016Transcript PPT
-
Feb 2016TranscriptPPT
-
Nov 2015TranscriptNotesPPT
-
Aug 2015TranscriptNotesPPT
Project Portfolio and Execution
The Co.’s product portfolio consists of residential projects, integrated and hi-tech townships, office and commercial projects including malls, and others. It also provides construction contracting services. At the end of FY 2022-23, since inception, Omaxe had approximately delivered 132 Mn. Sq. Ft. (12.26 Mn. Sq. Mtr.) of developed areas across various project categories. During FY22, it delivered 2.75 million square feet. These deliveries encompassed projects located in various cities such as Chandigarh, Lucknow, Faridabad, Ludhiana, and Vrindavan.[1]